Clusterin Levels in Plasma Predict Cognitive Decline and Progression to Alzheimer's Disease. [electronic resource]
- Journal of Alzheimer's disease : JAD 2015
- 1103-10 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1875-8908
10.3233/JAD-150036 doi
Aged Alzheimer Disease--blood Amyloid beta-Peptides--blood Analysis of Variance Clusterin--blood Cognition Disorders--complications Disease Progression Enzyme-Linked Immunosorbent Assay Female Follow-Up Studies Humans Male Middle Aged Neuropsychological Tests Peptide Fragments--blood Predictive Value of Tests Proportional Hazards Models Psychiatric Status Rating Scales tau Proteins--blood